Gainers
- PaxMedica PXMD stock increased by 24.3% to $1.0 during Monday's pre-market session. The market value of their outstanding shares is at $14.5 million.
- Precigen PGEN stock increased by 11.19% to $1.49. The company's market cap stands at $380.6 million.
- Moleculin Biotech MBRX stock increased by 10.71% to $0.74. The market value of their outstanding shares is at $21.9 million.
- Vivos Therapeutics VVOS stock moved upwards by 10.0% to $0.32. The company's market cap stands at $9.5 million.
- NRX Pharmaceuticals NRXP stock moved upwards by 9.32% to $0.45. The market value of their outstanding shares is at $31.6 million.
- Virpax Pharmaceuticals VRPX stock rose 8.46% to $0.99. The market value of their outstanding shares is at $11.5 million.
Losers
- Kodiak Sciences KOD stock fell 56.7% to $3.16 during Monday's pre-market session. The company's market cap stands at $165.4 million.
- Infinity Pharmaceuticals INFI stock decreased by 42.95% to $0.13. The market value of their outstanding shares is at $11.3 million.
- BioCardia BCDA shares decreased by 29.3% to $1.4. The market value of their outstanding shares is at $28.6 million.
- ViewRay VRAY shares decreased by 23.73% to $0.04. The company's market cap stands at $8.2 million.
- Verrica Pharmaceuticals VRCA shares declined by 19.79% to $5.98. The market value of their outstanding shares is at $250.2 million.
- Puma Biotechnology PBYI stock declined by 15.26% to $3.0. The company's market cap stands at $140.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
KODKodiak Sciences Inc
$9.998.05%
MBRXMoleculin Biotech Inc
$1.730.08%
NRXPNRX Pharmaceuticals Inc
$1.6818.3%
PGENPrecigen Inc
$0.75140.71%
PXMDPaxMedica Inc
$0.1450119.4%
VRCAVerrica Pharmaceuticals Inc
$0.70830.68%
VRPXVirpax Pharmaceuticals Inc
$0.3290-4.36%
VVOSVivos Therapeutics Inc
$4.72-7.87%
PBYIPuma Biotechnology Inc
$3.1010.3%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in